September 6, 2016 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Cepheid (NASDAQ:CPHD), was announced concerning whether the takeover of Cepheid by Danaher Corporation for $53 per share is unfair to NASDAQ:CPHD stockholders.

The investigation by a law firm concerns whether certain officers and directors of Cepheid breached their fiduciary duties owed to NASDAQ:CPHD investors in connection with the proposed acquisition.

On September 6, 2016, Cepheid (NASDAQ:CPHD) announced that it has entered into an agreement with Danaher Corporation (NYSE: DHR) under which Danaher will acquire all of the outstanding shares of Cepheid (NASDAQ:CPHD) common stock for $53 per share in cash, or a total enterprise value of approximately $4 billion including indebtedness and net of acquired cash.

However, the investigation concerns whether the offer is unfair to Cepheid (NASDAQ:CPHD stockholders. More specifically, the investigation concerns whether the Cepheid (NASDAQ:CPHD Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.

Cepheid reported that its annual Total Revenue rose from $331.21 million in 2012 to $538.58 million in 2015.